Facts, rumours and speculations about the mesothelioma epidemic

Respirology

Volumn 16, Issue 7, 2011, Pages 1018-1019

  Van Meerbeeck, Jan P ^a   Damhuis, Ronald ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Integraal Kankercentrum Rotterdam   (Netherlands)

Author keywords

epidemiology; mesothelioma; screening

Indexed keywords

ASBESTOS; CISPLATIN; FOLIC ACID ANTAGONIST; MESOTHELIN;

AUSTRALIA; BELGIUM; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; EDITORIAL; FACTUAL DATABASE; FRANCE; HUMAN; INCIDENCE; MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT INDICATION; UNITED KINGDOM; WESTERN EUROPE;

ASBESTOS; ENVIRONMENTAL HEALTH; HUMANS; LUNG DISEASES;

EID: 80053330238     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02020.x     Document Type: Editorial

References (18)

1. Giang L, Takahashi K, Park EK, et al,. Asbestos use and asbestos-related diseases in Asia: past, present and future. Respirology 2011; 16: 767-75.
2. Peto J, Decarli A, La Vecchia C, et al,. The European mesothelioma epidemic. Br. J. Cancer 1999; 79: 666-72. (Pubitemid 29046253)
3. Leigh J, Driscoll T,. Malignant mesothelioma in Australia, 1945-2002. Int. J. Occup. Environ. Health 2003; 9: 206-17. (Pubitemid 40292088)
4. Segura O, Burdorf A, Looman C,. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup. Environ. Med. 2003; 60: 50-5. (Pubitemid 36084228)
5. Hodgson JT, McElvenny DM, Darnton AJ, et al,. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br. J. Cancer 2005; 92: 587-93. (Pubitemid 40395543)
6. Tan E, Warren N, Darnton AJ, et al,. Projection of mesothelioma mortality in Britain using Bayesian methods. Br. J. Cancer 2010; 103: 430-6.
7. Pass HI, Carbone M,. Current status of screening for malignant pleural mesothelioma. Semin. Thorac. Cardiovasc. Surg. 2009; 21: 97-104.
8. Van Meerbeeck JP, Hillerdal G,. Screening for mesothelioma-more harm than good? Am. J. Respir. Crit. Care Med. 2008; 178: 781-2.
9. Fasola G, Belvedere O, Aita M, et al,. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial-an Alpe-Adria Thoracic Oncology multidisciplinary group study (ATOM 002). Oncologist 2007; 12: 1215-24. (Pubitemid 350106352)
10. Tiitola M, Kivisaari L, Huuskonen MS, et al,. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 2002; 35: 17-22. (Pubitemid 34028086)
11. Vierikko T, Jarvenpaa R, Autti T, et al,. Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings. Eur. Respir. J. 2007; 29: 78-84. (Pubitemid 46092001)
12. Mastrangelo G, Ballarin MN, Bellini E, et al,. Feasibility of a screening programme for lung cancer in former asbestos workers. Occup. Med. 2008; 58: 175-80.
13. Roberts HC, Patsios DA, Paul NS, et al,. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J. Thorac. Oncol. 2009; 4: 620-8.
14. Creaney J, Robinson BW,. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein. Hematol. Oncol. Clin. North Am. 2005; 19: 1025-40. (Pubitemid 41736040)
15. Hollevoet K, Van Cleemput J, Thimpont J, et al,. Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals a prospective longitudinal cohort study. J. Thorac. Oncol. 2011; 6: 889-95.
16. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al,. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 2003; 21: 2636-44. (Pubitemid 46606305)
17. Van Meerbeeck JP, Manegold C, Gaafar R, et al,. A randomized phase III study of cisplatine with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the EORTC lung cancer group and NCIC. J. Clin. Oncol. 2005; 23: 6881-9.
18. Treasure T, Waller D, Swift S, et al,. Radical surgery for mesothelioma. BMJ 2004; 328: 237-8. (Pubitemid 38168126)